Logo image of KRMN

KARMAN HOLDINGS INC (KRMN) Stock Fundamental Analysis

NYSE:KRMN - New York Stock Exchange, Inc. - US4859241048 - Common Stock - Currency: USD

44.205  +0.49 (+1.13%)

Fundamental Rating

4

KRMN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 65 industry peers in the Aerospace & Defense industry. While KRMN seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, KRMN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year KRMN was profitable.
KRMN Yearly Net Income VS EBIT VS OCF VS FCFKRMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

KRMN has a Return On Assets of 1.45%. This is comparable to the rest of the industry: KRMN outperforms 43.08% of its industry peers.
With a Return On Equity value of 3.64%, KRMN perfoms like the industry average, outperforming 47.69% of the companies in the same industry.
KRMN's Return On Invested Capital of 7.18% is fine compared to the rest of the industry. KRMN outperforms 64.62% of its industry peers.
The Average Return On Invested Capital over the past 3 years for KRMN is below the industry average of 8.35%.
The last Return On Invested Capital (7.18%) for KRMN is above the 3 year average (6.11%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.45%
ROE 3.64%
ROIC 7.18%
ROA(3y)0.06%
ROA(5y)N/A
ROE(3y)0.31%
ROE(5y)N/A
ROIC(3y)6.11%
ROIC(5y)N/A
KRMN Yearly ROA, ROE, ROICKRMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 5 -5

1.3 Margins

KRMN has a Profit Margin (3.68%) which is comparable to the rest of the industry.
KRMN has a Operating Margin of 18.41%. This is amongst the best in the industry. KRMN outperforms 90.77% of its industry peers.
Looking at the Gross Margin, with a value of 38.27%, KRMN is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
Industry RankSector Rank
OM 18.41%
PM (TTM) 3.68%
GM 38.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KRMN Yearly Profit, Operating, Gross MarginsKRMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), KRMN is destroying value.
The number of shares outstanding for KRMN remains at a similar level compared to 1 year ago.
KRMN has a worse debt/assets ratio than last year.
KRMN Yearly Shares OutstandingKRMN Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
KRMN Yearly Total Debt VS Total AssetsKRMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 7.49 indicates that KRMN is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 7.49, KRMN belongs to the best of the industry, outperforming 81.54% of the companies in the same industry.
A Debt/Equity ratio of 1.15 is on the high side and indicates that KRMN has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.15, KRMN is doing worse than 80.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF N/A
Altman-Z 7.49
ROIC/WACC0.68
WACC10.53%
KRMN Yearly LT Debt VS Equity VS FCFKRMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

KRMN has a Current Ratio of 3.34. This indicates that KRMN is financially healthy and has no problem in meeting its short term obligations.
KRMN has a Current ratio of 3.34. This is in the better half of the industry: KRMN outperforms 69.23% of its industry peers.
KRMN has a Quick Ratio of 3.23. This indicates that KRMN is financially healthy and has no problem in meeting its short term obligations.
KRMN's Quick ratio of 3.23 is amongst the best of the industry. KRMN outperforms 89.23% of its industry peers.
Industry RankSector Rank
Current Ratio 3.34
Quick Ratio 3.23
KRMN Yearly Current Assets VS Current LiabilitesKRMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

KRMN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 191.21%, which is quite impressive.
The Revenue has grown by 22.99% in the past year. This is a very strong growth!
EPS 1Y (TTM)191.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)22.99%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, KRMN will show a very strong growth in Earnings Per Share. The EPS will grow by 101.40% on average per year.
The Revenue is expected to grow by 20.73% on average over the next years. This is a very strong growth
EPS Next Y306.97%
EPS Next 2Y151.15%
EPS Next 3Y101.4%
EPS Next 5YN/A
Revenue Next Year23.67%
Revenue Next 2Y21.51%
Revenue Next 3Y20.73%
Revenue Next 5YN/A

3.3 Evolution

KRMN Yearly Revenue VS EstimatesKRMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 200M 400M 600M
KRMN Yearly EPS VS EstimatesKRMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 442.05 indicates a quite expensive valuation of KRMN.
Based on the Price/Earnings ratio, KRMN is valued a bit more expensive than 67.69% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.46. KRMN is valued rather expensively when compared to this.
KRMN is valuated quite expensively with a Price/Forward Earnings ratio of 70.47.
Based on the Price/Forward Earnings ratio, KRMN is valued a bit more expensive than the industry average as 66.15% of the companies are valued more cheaply.
KRMN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.30.
Industry RankSector Rank
PE 442.05
Fwd PE 70.47
KRMN Price Earnings VS Forward Price EarningsKRMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

61.54% of the companies in the same industry are cheaper than KRMN, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 63.06
KRMN Per share dataKRMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

KRMN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
KRMN's earnings are expected to grow with 101.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.44
PEG (5Y)N/A
EPS Next 2Y151.15%
EPS Next 3Y101.4%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KRMN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KARMAN HOLDINGS INC

NYSE:KRMN (6/4/2025, 11:46:37 AM)

44.205

+0.49 (+1.13%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change-10.03%
Market Cap5.84B
Analysts87.27
Price Target39.53 (-10.58%)
Short Float %3.13%
Short Ratio1.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)4.19%
EPS NQ rev (3m)N/A
EPS NY rev (1m)7.24%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)2.09%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.9%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 442.05
Fwd PE 70.47
P/S 16.92
P/FCF N/A
P/OCF N/A
P/B 16.74
P/tB N/A
EV/EBITDA 63.06
EPS(TTM)0.1
EY0.23%
EPS(NY)0.63
Fwd EY1.42%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.61
BVpS2.64
TBVpS-0.61
PEG (NY)1.44
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.45%
ROE 3.64%
ROCE 8.1%
ROIC 7.18%
ROICexc 8.39%
ROICexgc 23.31%
OM 18.41%
PM (TTM) 3.68%
GM 38.27%
FCFM N/A
ROA(3y)0.06%
ROA(5y)N/A
ROE(3y)0.31%
ROE(5y)N/A
ROIC(3y)6.11%
ROIC(5y)N/A
ROICexc(3y)6.19%
ROICexc(5y)N/A
ROICexgc(3y)19.58%
ROICexgc(5y)N/A
ROCE(3y)6.9%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF N/A
Debt/EBITDA 4.17
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.34
Quick Ratio 3.23
Altman-Z 7.49
F-ScoreN/A
WACC10.53%
ROIC/WACC0.68
Cap/Depr(3y)56.34%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.6%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)191.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y306.97%
EPS Next 2Y151.15%
EPS Next 3Y101.4%
EPS Next 5YN/A
Revenue 1Y (TTM)22.99%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year23.67%
Revenue Next 2Y21.51%
Revenue Next 3Y20.73%
Revenue Next 5YN/A
EBIT growth 1Y31.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year116.22%
EBIT Next 3Y46.12%
EBIT Next 5YN/A
FCF growth 1Y220.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.09%
OCF growth 3YN/A
OCF growth 5YN/A